Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
09/2000
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2361277A1 49 human secreted proteins
09/21/2000CA2332375A1 Cervical ripening agent and cervical ripening method
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036091A1 5t4 tumour-associated antigen for use in tumour immunotherapy
09/20/2000EP1036078A1 Thienopyrimidines
09/20/2000EP1035833A1 Compositions for nasal administration
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000CN1267191A Composition and method for treating penile erectile dysfunction
09/20/2000CN1266711A Chinese medicine for treating proliferation of mammary gland
09/20/2000CN1056609C Benzoyl guanidines, their production and their use in medicinal compositions
09/20/2000CN1056607C Tricyclic pyrazole derivs.
09/20/2000CN1056510C Method for increasing galactopoiesis power of female bovidae
09/19/2000US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders
09/19/2000US6121276 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
09/19/2000US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders
09/19/2000US6121230 Administering polypeptide acting as vascular endothelial growth factor antagonist to treat and/or prevent endometriosis
09/19/2000US6121016 DNA encoding human follicle stimulating hormone receptor, vectors and cells containing such DNA, and methods of use thereof
09/19/2000US6120761 Mixture containing histidine stabilizer
09/19/2000CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them
09/19/2000CA2071538C Hpth (1-37) fragment, its production, drug containing it and its use
09/14/2000WO2000053800A1 METHOD TO SEARCH FOR MALE ANTIFERTILITY DRUGS BASED ON PHGPx ACTIVITY DETERMINATION
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053619A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
09/14/2000WO2000053618A1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
09/14/2000WO2000053602A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053562A1 Retinoid antagonists and use thereof
09/14/2000WO2000053228A2 Use of niaouli essential oil as transdermal permeation enhancer
09/14/2000WO2000053185A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053183A1 Medicament against dysmenorrhoea and premenstrual syndrome
09/14/2000WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation
09/14/2000WO2000037422A3 Ion channel modulating agents
09/14/2000WO2000037109A3 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation
09/14/2000CA2367130A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2366615A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2364470A1 Medicament against dysmenorrhoea and premenstrual syndrome
09/14/2000CA2359218A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
09/13/2000EP1034265A1 Human cdc10 homolog
09/13/2000EP1034002A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
09/13/2000CN1266054A Aryl carboxylic acid and tetrazole derivant
09/13/2000CN1056374C Tricyclic diazepine vasopression antagonists
09/13/2000CN1056288C Fuxin powder medicine and preparation process thereof
09/12/2000US6117998 A1 adenosine receptor antagonists
09/12/2000US6117989 Human calcium-binding proteins
09/12/2000US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions
09/12/2000US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
09/12/2000US6117837 Inhibiting proinflammatory cytokine production
09/12/2000US6117442 A core comprising androgen as a therapeutical agent and an elastomeric membrane encasing the core comprising polysiloxane containing 3,3,3 trifluoropropylgroup attached to silicon atom of siloxane unit
09/12/2000US6117421 Method for promoting cell growth and immunosuppression using chaperonin
09/12/2000CA2051375C Process and compositions for the isolation of human relaxin
09/08/2000WO2000052148A2 Substances for controlling fertility
09/08/2000WO2000051986A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
09/08/2000WO2000051979A1 C16 unsaturated fp-selective prostaglandins analogs
09/08/2000WO2000051973A1 Cyclobutene-3,4-dione derivatives, preparation method and therapeutic use
09/08/2000WO2000051972A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
09/08/2000WO2000051618A1 (ANDROST-5-EN-17β-YL)ALKYL SULFOXIDES AND SULFONES AND THEIR USE FOR CONTROL OF FERTILITY
09/08/2000WO2000051546A2 Bupropion metabolites and methods of their synthesis and use
09/08/2000WO2000027414A3 Inhibition of the formation of vascular hyperpermeability
09/08/2000WO2000012720A3 Elongase genes and uses thereof
09/08/2000WO2000000604A9 Methods and compositions for modulating spermatogenesis
09/08/2000CA2365032A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
09/08/2000CA2362361A1 Bupropion metabolites and methods of their synthesis and use
09/08/2000CA2330541A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
09/07/2000DE19910394A1 Substanzen für die Fertilitätskontrolle Substances for fertility control
09/07/2000DE19860438C1 Verfahren zur Herstellung von Autovakzinen zur Behandlung von Chlamydiosen von Säugetieren und Menschen A process for the production of vaccines for the treatment of auto chlamydioses of mammals and humans
09/06/2000EP1033366A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists
09/06/2000EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION
09/06/2000EP1032662A1 Methods and compositions for immunomodulation
09/06/2000EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
09/06/2000EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
09/06/2000EP1032399A1 Progestin therapy with controlled bleeding
09/06/2000EP1032398A1 Methods for treating postmenopausal women using ultra-low doses of estrogen
09/06/2000CN1265647A Acrylic metalloprotease inhibitor
09/06/2000CN1265645A Urokinase inhibitors
09/06/2000CN1265597A Composition comprising propolis and at least an essential oil
09/06/2000CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound
09/05/2000US6114338 Heterocyclic compounds
09/05/2000US6114334 Piperazine derivatives as therapeutic agents
09/05/2000US6113906 Water-soluble non-antigenic polymer linkable to biologically active material
09/05/2000US6113899 Antagonists of chaperonin 10
08/2000
08/31/2000WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease
08/31/2000WO2000050562A2 Dna encoding snorf25 receptor
08/31/2000WO2000050071A1 PROTEIN OmpA OF KLEBSIELLA PNEUMONIAE ASSOCIATED WITH THE HCG HORMONE OR A COMPOUND INVOLVED IN CELL PROLIFERATION OR FERTILITY
08/31/2000WO2000050066A1 Treatment of infertility
08/31/2000WO2000050065A1 Treatment of infertility
08/31/2000WO2000050046A1 Stabilized oral pharmaceutical composition containing iodide and iodate and method
08/31/2000WO2000030623A3 Agent for lowering prolactin
08/31/2000WO2000026236A3 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function
08/31/2000WO2000018795A9 Compositions and methods for wt1 specific immunotherapy
08/31/2000DE19908762A1 Verwendung von Dienogest in hoher Dosierung Use of dienogest in high doses
08/31/2000CA2363074A1 Treatment of infertility
08/31/2000CA2362940A1 Treatment of infertility
08/31/2000CA2362906A1 Dna encoding snorf25 receptor